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Abstract: The objective of this study was to compare the effects of three different vitrification solutions on the development of
pronuclear-stage (PN) Dinnyes mouse embryos into blastocyst stage after vitrification by solid surface vitrification (SSV) technique.
For this aim, it was compared three experimental groups and a control group. Experimental groups were distinguished each other
by the vitrification solution used in SSV. It was used 4 % Ethylene Glycol (EG) at 37 ºC equilibration temperature in the first group
(SSV-EG), 4% Dimethyl Sulfoxide (DMSO) at room temperature in the second group (SSV-DMSO) and 4% Propylene Glycol (PG) at
room temperature in the third group (SSV-PG). After vitrification, the survived embryos were cultured to blastocyst stage in KSOM.
It was determined a significant difference between the groups of SSV-EG and SSV-PG at developing rate to 2-cell stage (P < 0.05).
Similarly, SSV-PG demonstrated significant differences with SSV-DMSO and the control group at developing rate to 3-8-cell stage
(P < 0.05). When compared the rates of developing to morula stage among the groups, it was determined significant differences
between SSV-PG and the control group at (P < 0.05); and between SSV-DMSO and SSV-PG (P < 0.01). Finally, it was compared
the developing rates into blastocyst stage and found that SSV-EG demonstrated significant differences with SSV-PG and SSV-DMSO
(P < 0.01). This study has shown that EG, DMSO and PG with trehalose can be used effectively as a cryoprotective agent in the
quick freezing of pronuclear-stage mouse embryos. Finally, additional studies are needed to optimize the SSV method in further
stage mouse embryos.
Key Words: Vitrification, pronuclear-stage mouse embryos, ethylene glycol, dimethyl sulfoxide, propilen glycol, trehalose

SSV Tekni¤i ile Dondurulan Pronükleer Fare Embriyolar›n›n Dondurulmas›nda Üç Farkl›
Kriyoprotektan Maddenin Etkileri
Özet: Çal›flman›n amac›, fare zigotlar›n›n, Kat› Yüzey Vitrifikasyonu (Solid Surface Vitrifikasyon; SSV) tekni¤i ile vitrifikasyon
iflleminin ard›ndan blastosist safhas›na dek geliflimleri üzerine, üç farkl› vitrifikasyon solusyonunun etkilerini karfl›laflt›rmakt›r. Bu
amaçla, üç deney ve bir kontrol grubu oluflturulmufltur. Deney gruplar›, SSV tekni¤i kapsam›nda farkl› vitrifikasyon solusyonlar›n›n
kullan›lmas› ile birbirlerinden ayr›lmaktad›r. Birinci grupta % 4 EG ve 37 ºC ekilibrasyon ›s›s› (SSV-EG); ikinci grupta % 4 DMSO ve
oda ›s›s›nda ekilibrasyon (SSV-DMSO); son grupta ise oda ›s›s›nda ekilibrasyon ve %4 PG (SSV-PG) parametreleri kullan›lm›flt›r.
Virifikasyon ifllemi sonras›nda canl› kalan embriyolar KSOM medyumu içinde blastosist safhas›na dek kültüre edilmifltir. SSV-EG ve
SSV-PG gruplar› aras›nda 2-hücreli safhaya geliflim oranlar›nda istatistiksel olarak önemli bir fark saptanm›flt›r (P < 0,05). Benzer
olarak, SSV-PG ve SSV-DMSO gruplar› aras›nda da 3-8-hücreli safhaya geliflim oranlar›nda istatistiksel olarak önemli bir fark
saptanm›flt›r (P < 0,05). Gruplar aras›nda morula safhas›na geliflim oranlar› karfl›laflt›r›ld›¤›nda, SSV-PG ve kontrol grubu aras›nda
(P < 0,05) ve SSV-DMSO ile SSV-PG gruplar› aras›nda (P < 0,01) istatistiksel olarak önemli bir fark saptanm›flt›r. Sonuç olarak,
blastosist safhas›na geliflim oranlar› incelendi¤inde, SSV-EG grubunun SSV-PG ve SSV-DMSO gruplar› ile önemli derecede farkl›l›k
gösterdi¤i belirlenmifltir (P < 0,01). Bu çal›flma, EG, DMSO ve PG’nin, tek hücreli fare embriyolar›n›n h›zl› dondurulmas›nda
kriyoprotektan ajan olarak etkin bir flekilde kullan›labilece¤ini göstermifltir. Özetle; geliflimin daha ileri safhalar›ndaki fare
embriyolar›n›n dondurulmas› protokollerini optimize etmek için ek baz› deneysel çal›flmalara ihtiyaç duyulmaktad›r.
Anahtar Sözcükler: Vitrifikasyon, pronükleer safhada fare embriyosu, etilen glikol, dimetil sülfoksit, propilen glikol, trehaloz
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Introduction
The discovery of cryoprotective activity of glycerol for
semen have given scientists opportunity to perform
research on cryopreservation embryos. The first succesful
offspring frozen-thawed embryos were reported in mice
and later in other laboratory animals in 1972 (1). The
generation of transgenic animals is equally important for
basic science and medical, pharmaceutical and agricultural
applications. DNA microinjection into pronuclear-stage
(PN) embryos is the most frequently used method for the
production of transgenic animals (2-4). An efficient
pronuclear microinjection system requires the collection
of a large number of pronuclear-stage embryos at once
and a good synchrony among the different technological
steps. To achieve this, large colonies of mice have to be
maintained, increasing the required labor and expenses.
There is often a discrepancy between the number of
fertilized eggs available for microinjection and the
number of synchronous foster mothers as recipients for
embryo transfer (5). In order to overcome these
problems, it would be useful to utilize cryopreserved
pronuclear-stage mouse embryos for pronuclear
microinjection. (6-9). Research in cryopreservation
techniques have included studies about the type and
concentration of cryoprotectant, cooling and freezing
rates, seeding and plunging temperatures, warming
temperatures and rates, and methods of cryoprotectant
removal. Since succesful embryo cryopreservartion has
been reported for several mammalian species, general
reviews are available on the technological and applied
aspects of the freezing of mammalian embryos (10-15).
Since Rall and Fahy (12) described the first successful
vitrification of mouse embryos, many investigators have
studied cryopreservation of embryos by vitrification
(16,17). Vitrification is defined as glass-like solidification
and/or a complete avoidance of ice crystal formation
during cooling. Furthermore, vitrification can eliminate
mechanical damages caused by intra-or extracellular ice
crystals, and chilling damages due to prolonged exposure
to suboptimal temperatures. Vitrification can offer a
rapid and simple alternative to cryopreserve oocytes and
embryos, without using of expensive equipment. Some
suitable vitrification solutions such as mixtures of
dimethyl sulfoxide (DMSO), glycerol and propylene glycol
(PG), ethylene glycol (EG), and trehalose and sucrose
(8,9). Subsequently, glycerol, PG and EG have been
reported as effective for vitrifying mouse embryos both
in combination and as simple permating cryoprotectants
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(11,18,19). The vitrification solution contains DMSO and
PG as permeable agents, polyethylene glycol (PEG) as a
macro molecule compound. The inclusion of a macro
molecule to the solution facilitates vitrification and also
Bovine Serum albumine (BSA), Ficoll and Poly Vinly
Pyrolidone (PVP) are widely used for this purpose
(11,12,18). The sensitivity of embryos to
cryoprotectants and cryopreservation is variable and
highly dependent on the developmental stages of
embryos. It has been known that the cryopreservation of
PN mouse embryos has always been more difficult than
that of other stages. Pronuclear-stage mouse embryos
have been successfully cryopreserved either by
conventional slow freezing or vitrification methods (69,13) reported high success rates with a new vitrification
method that requires a pre-cooled metal surface (hence
its name: solid surface vitrification, SSV) to vitrify
matured bovine oocytes and pronuclear-stage mouse
embryos (8,9,20). The method is very simple and
inexpensive. Furthermore, the metal surface cooled with
LN2, the containerless cooling and the small drop size
offers advantages such as a more efficient heat transfer
and subsequently, increased cooling rates. In this study, in
vitro viability of pronuclear-stage mouse embryos was
examined after vitrification with three different
cryoprotectants. The aim of this study was to develop an
efficient and inexpensive protocol for cryopreservation
and storage technique of PN embryos until their use for
manipulations.

Materials and Methods
Animals, superovulation and embryo collection
Chemicals were purchased from Sigma Chemical Co
(St Louis, MO, USA) unless otherwise indicated. Animal
care and use procedures were in accordance with the
Instutional Guide for the Care and Use of Laboratory
Animals and were approved by the Research Institute of
Genetic Engineering and Biotechnology (RIGEB) Animal
Care and Use committee. Five-six weeks old hybrid
(C57BL/6J x BALB/c) CB6F1 mice were used. The animals
were housed in 14:10 hr light/dark cycle (lights on at
o
05.00 a.m.) at 21 ± 0.5 C and humidity of 50-60%.
Females were superovulated by intra-peritoneal (i.p.)
injections of 5 IU pregnant mare’s serum gonadotropin
(PMSG; G-4877) at 13.00 hr, followed by an i.p.
injection of 5 IU human chorionic gonadotropin (hCG;
Pregnyl, Organon) 48 hr later (21) then placed
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individually with stud males. Successfully mated females
were identified by vaginal plugs. Approximately 19-20 hr
post-hCG injection oviducts were excised and PN embryos
with cumulus cells were released from oviductal ampullae
then transferred into drops of M2 medium supplemented
with hyaluronidase (80 IU/ml) for 3 min (21). Finally, all
embryos were washed three times in M2 medium, and PN
embryos were selected for vitrification studies.
Vitrification and Thawing
SSV vitrification procedures were employed during
the experiments. The SSV method was originally
described by Dinnyes et al. (20) and slightly modified in
this study. All solutions used in this study were prepared
in M2 supplemented with 4 mg/ml BSA (A-9647). The
effects of the vitrification solutions was tested before
vitrification. Therefore PN embryos were exposed to the
equilibration and vitrification solutions, and without the
cooling step, moved directly into the sugar solutions, and
rinsed three times M2 medium. 15 to 20 PN embryos
were transferred into 50 µl drops of three different
0
mediums: i) 4% EG (E-9129) in M2 medium at 37 C ;
ii) 4% DMSO (D-2650); iii) 4% PG (P -1009) in M2
medium at 21 0C for 12-15 min, and then the PN
embryos were rinsed three times 25 ml drops of
vitrification medium of i) 35 % EG, 5%
Polyvinylpyrrolidone (PVP), 0.4 M Trehalose ii) 35 %
DMSO, 5% PVP, 0,4 M Trehalose iii) 35 % PG, 5% PVP,
0,4 M Trehalose in M2 medium at 21 0C for 20-30 sec,
respectively. PN embryos exposed to vitrification solution
were either placed into a 0.3 M trehalose solution (for
solution toxicity experiments), or 15-20 embryos were
aspirated into a pipette with 1-2 µl vitrification solution
and dropped onto a metal surface pre-cooled to -150 to
-180 ºC (Figure) where they were instantaneously
vitrified. After vitrifying, five drops were moved with a
cooled forceps into a 1-ml cryotube (Nunc;
Cat.No:343958,Roskilde, Denmark) and stored in LN2
either for long-term (from several days to 2 to 4 weeks)
or warmed after storage approximately 12-hr. All
solutions in the microdrops remained transparent during
cooling and warming, which is one indication that the
solutions vitrified. Warming was performed by dropping
the vitrified droplets from the cryotube directly into a
petri-dish containing 500 ml 0.3 M trehalose solution at
37 ºC for 3 min. Warmed embryos were washed in M2
three times and kept in the last M2 drop for 10 min
before transferring them into in vitro culture medium

Figure. The solid surface vitrification (SSV) device: a metal cube covered
with aluminum foil, partially submerged into liquid nitrogen
(LN2) (8,20).

(Potassium Simplex Optimized Medium, which is denoted
KSOM) (22).
Preparation of culture media
The embryos were cultured in KSOM supplemented
with BME (5 ml/ml) ( M7145) and MEM (2.5 ml/ml)
(B6766) amino acids (22-25). Osmolarity was measured
by freeze-point depression osmometer (Osmomat 030,
Gonotec GmbH) was 265 ± 10 mOsm
Embryo Culture and Evaluation
Culture plates (35-mm tissue culture plate;
Nunc150288) were equilibrated with 5% CO2 in air at 37
ºC overnight. PN embryos were transferred from M2
medium into culture drops following three times washing in
culture medium and cultured in groups of 10 per 10 ml
droplet of medium overlaid with embryo-tested mineral oil
(M 8410) in an incubator with 5 % CO2 in air at 37oC for
5 days (120 hr post-hCG), without replacement with fresh
medium. During in vitro culture, embryo development was
evaluated every 24 hr 2-cell, 3-8-cell, morula, and
expanded blastocyst stages were distinguished.
Statistical Analysis
Embryo developmental data was collected from at
least three replicates. Vitrified- thawed PN embryos on
the developmental effects in three different vitrification
solutions were compared with Chi-square analysis.
Differences of P < 0.05 or P < 0.01 were considered
significant. The data analysis was carried out by using
Graphpad Software Program (Version 2.02, Dr. Granger,
LSU Medical Center).
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Results
In the present study, three experimental groups and a
control group were compared, but also the toxicity of the
cryoprotectants were compared. No significant
differences have been found between the immediate
survival or cleavage rates of embryos exposed to the
solutions used during the vitrification procedures and that
of the nontreated controls. Experimental groups were
distinguished each other by the vitrification solution used
in SSV. Equilibration were performed 4% EG at 37 ºC
temperature in the first group (SSV-EG), 4% DMSO at
room temperature (RT) in the second group (SSV-DMSO)
and 4% PG at RT in the third group (SSV-PG). After
vitrification and thawing, survived embryos were cultured
to blastocyst stage in KSOM. According to chi-square test
results, a significant difference between the groups of
SSV-EG and SSV-PG at developing rate to 2-cell stage (P
< 0.05, Table) were determined. Similarly, SSV-PG
demonstrated significant differences with SSV-DMSO and
the control group at developing rate to 3-8-cell stage (P
< 0.05). When compared the rates of developing to
morula stage among the groups, significant differences
between SSV-PG and the control group at P < 0.05 were
determined; and between SSV-DMSO and SSV-PG at P <
0.01. Finally, the developing rates into blastocyst stage
were compared and it was found that SSV-EG

demonstrated significant differences with SSV-PG and
SSV-DMSO at P < 0.01.

Discussion
The results of this study demonstrate that vitrification
(SSV-EG group) can result in high developmental rates
for PN mouse embryos not lower than that of the
controls. Furthermore, three permeating cryoprotectants
(EG, DMSO and PG) with non-permeating sugars
(trehalose) were all found to be efficient for vitrification
of pronuclear-stage embryos. Vitrification of pronuclearstage embryos would be very important for transgenic
studies in mice to overcome the potential discrepancies
between the need and the availability of appropriate
developmental stage embryos for microinjection and
subsequent transfer into foster mothers. Vitrification
depends on the concentration and type of cryoprotectants
and equilibration time is an important element of the
vitrification procedure. The cryoprotectant penetrating
into the embryo is essential to achieve a vitrifiable
concentration during the rapid cooling step. Following the
equilibration step, a short exposure to high
concentrations of cryoprotectants in the vitrification
solution has a double effect on the embryos. The principal
factor affecting successful cryopreservation in which only

Table. Development of vitrified PN-stage mouse embryos to the blastocyts-stage in three different solution.

Methods

Equilibration
solution and
time

Number of
frozen PN
embryos

Number of
cultured PN
embryos

2-cell
(%)

3-8-cell
(%)

Morula
(%)

Blastocyst
(%)

SSV-EG

4 % EG
15 min
37 0C

105*

98 (93.3)

91 (92.8)a

76(77.5)ab

68 (69.3)abcd

52 (53.06)c

4 % DMSO
15 min
RT

142*

138 (97.1)

122 (88.4)ab

117 (84.7)a

109 (78.9)abc

43 (31.1)d

SSV-PG

4 % PG
15 min
RT

119*

117 (98.3)

97 (82.9)b

87 (74.3)b

73 (62.3)ad

35 (29.9)d

Control

-

-

51*

48 (94.0)ab

46 (90.0)a

40 (78.4)bcd

28 (54.9)c

SSV-DMSO

EG: Ethylene glycol, PG: Propylene glycol, DMSO: Dimethyl sulfoxide, RT: Room temperature,
*
Pooled data from three replicates.
a-b-c-d
Different superscripts in the same column denote significant difference at ( a,b: P < 0.05; c,d: P < 0.01)
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one type cryoprotectant is used of mammalian embryos
one the type of cryoprotectans used. In this study, PN
mouse embryos were vitrified in high concentration of
EG, DMSO and PG solution by exposure. It has been
reported that the cell is highly permeable to EG and
DMSO may easily permeate the embryo to cause
vitrification over a short time exposure (30 seconds)
(26,27). The cryoproptectant also may easily efflux form
the embriyonic cells without causing serious osmotic
injury during warming and dilution in 0.5 M sucrose +
PBS. Trehalose has been successfully used for cooling
embryos in combination with other reagents, EG (8,20)
and DMSO (9), PG (9). On the other hand, this study
demonstrated that trehalose was also effective when
utulized in combination with EG, DMSO and PG. EG has
been used successfully for freezing several mammalian
embryos (8,20) compared with other cryoprotectant
DMSO, PG and seems to have a very low toxicity even
when used in high concentration (18). Moreover, EG
penetrates easily inside embryo blastomeres and restricts
ice crystal formation. Recently, Yokohama et al (28)
showed that EG permeates more slowly through the
cellular membrane of mouse oocytes than PG, acetamide
or DMSO. Szell et al (27) showed that sheep and bovine
embryos are more permeable to EG than glycerol or PG.
It has also been shown that EG provides better
cryoprotection for mouse embryos that slowly colled to
0
below - 60 C than glycerol or DMSO (29). PG appears to
be efficient in cryopreservation. PG is higly stable in the
amorphous state, and thus, limits ice formation, it has
also appears to be less toxic than DMSO and has been
used in cryopreserving of early stage embryos. Mouse
oocytes and PN embryos are more sensitive to
cryopreservation than 2- to 8-cell or later stage embryos
(30), probably due to stage-dependent changes in the
membrane characteristics and other cytoplasmic factors.
Cryopreservation of pronuclear-stage embryos would be
very important for transgenic studies in mice to overcome
the potential discrepancies between the need and the
availability of appropriate developmental stage embryos
for microinjection and subsequent transfer into foster
mothers. Therefore, several scientists have investigated
suitable techniques for cryopreservation of PN mouse
embryos (6-10). The composition of the cryoprotectants
is an important factor for vitrification. The extracellular,
non-permeating cryoprotectants used during the SSV
procedures have various beneficial effects on the
vitrification process. The macromolecules of PVP elevated

the viscosity of the solution without any major osmotic
effects (31), and have been shown to decrease the rate of
zonal disruption during vitrification (32). Trehalose is a
low molecular weight non-permeating disaccharide which
has an important role in preventing changes to cellular
membrane during dehydration, although the exact
mechanism of its action has not been understood yet
(33). The use of a mixture of a fast penetrating
cryoprotectant (EG), a viscosity-increasing compound
(PVP) and a membrane-stabilizing sugar (trehalose)
assured that even a short exposure to the solution would
result in vitrification. If one vitrification method can be
succesfully applied to every developmental stage of
embryos, the cryopreservation of embryos will become
simplier and more practical.The presence of intracellular
cryoprotectants, permeating into the embryo (for
example EG, DMSO, glycerol) is very important during
the vitrification process (31). Ethylene glycol is a low
molecular weight permeating cryoprotectant, and in
addition it has an important role in stabilizing the cellular
membranes during cryopreservation. In mouse oocytes it
was demonstrated that EG permeates more slowly
through the cellular membrane than DMSO, acetamide or
PG (28).
In conclusion, in this study it was demonstrated that
pronuclear-stage mouse embryos were succesfully
vitrified in a EG, DMSO and PG under the same conditions
and dilutions via SSV techniques. This study has shown
that, EG, DMSO and PG with trehalose can be used
effectively as a cryoprotective agent in the quick freezing
of pronuclear-stage mouse embryos. Additionally, it has
been demonstrated that there is no statistical difference
between EG, DMSO and control groups at cleavage rates.
However, EG group had the highest blastocyst rate when
comparing with the other groups including the control.
Furthermore, all vitrification procedures are carried out
at room temperature. Finally, additional studies are
needed to optimize the SSV method in further stage
mouse embryos.
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